✦ LIBER ✦

Cellular pharmacology of idarubicinol in multidrug-resistant LoVo cell lines

✍ Scribed by Giuseppe Toffoli; Giuseppe Corona; Federico Simone; Marco Gigante; Sergio De Angeli; Mauro Boiocchi

Publisher: John Wiley and Sons
Year: 1996
Tongue: French
Weight: 919 KB
Volume: 67
Category: Article
ISSN: 0020-7136
DOI: 10.1002/(sici)1097-0215(19960703)67:1<129::aid-ijc21>3.0.co;2-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quantitative proteome analysis of multid

Quantitative proteome analysis of multidrug resistance in human ovarian cancer cell line

✍ Sang-Lin Li; Feng Ye; Wei-Jun Cai; Huai-Dong Hu; Peng Hu; Hong Ren; Fu-Fan Zhu; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB

## Abstract In order to understand the molecular mechanisms of multidrug resistance (MDR) in ovarian cancer, we employed the proteomic approach of isobaric tags for relative and absolute quantification (iTRAQ), followed by LC‐MS/MS, using the cisplatin‐resistant COC1/DDP cell line and its parental

Measurement of P-Glycoprotein Expression

Measurement of P-Glycoprotein Expression in Multidrug-Resistant Human Neuroblastoma Cell Lines Using Self-Competitive Binding Assay

✍ Andrey Levchenko; Bipin M. Mehta; Barbara A. Spengler; Archana A. Narkar; Rosa F 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Molecular and cellular characterization

Molecular and cellular characterization of drug resistant hamster cell lines with alterations in ribonucleotide reductase

✍ Aaron Y. Tagger; Jim A. Wright 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 French ⚖ 1020 KB

Ribonucleotide reductase consists of 2 protein components frequently called M I and M2. Hydroxyurea specifically inhibi t s DNA synthesis by interacting with the M2 protein and destroying a unique tyrosyl-free radical. We have carried out a molecular and cellular characterization of 2 Chinese hamste

Modulation of multidrug resistance by ve

Modulation of multidrug resistance by verapamil or mdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers in mdr-resistant human carcinoma (LoVo) line

✍ Licia Rivoltini; Mario P. Colombo; Rosanna Supino; Dario Ballinari; Takashi Tsur 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 674 KB

Two sublines were derived from the colon adenocarcinoma line LoVo, the first one was sensitive (LoVolH) and the second one was made resistant to doxorubicin (LoVolDx). When tested for susceptibility to lysis by different types of immune effectors, LoVo/Dx appeared more sensitive than LoVo/H to the k

Differential over-expression of mdr1 gen

Differential over-expression of mdr1 genes in multidrug-resistant rat glioblastoma cell lines selected with doxorubicin or vincristine

✍ Brigitte Schott; Sanae Bennis; Philippe Pourquier; Colette Ries; Danielle Londos 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 923 KB

MRP gene overexpression in a human doxor

MRP gene overexpression in a human doxorubicin-resistant SCLC cell line: Alterations in cellular pharmacokinetics and in pattern of cross-resistance

✍ Monica Binaschi; Rosanna Supino; Romolo A. Gambetta; Giuseppe Giaccone; Ennio Pr 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 697 KB

## Abstract The development of non‐P‐glycoprotein‐mediated multidrug resistance is a frequent event among lung‐cancer cell lines. In an attempt to understand the underlying mechanisms of this phenotype, we have selected a multi‐drug‐resistant subline (POGB/DX) __in vitro__ for doxorubicin resistanc